Pfizer (PFE) has FDA approval for a new drug that "blocks the CCR5 co-receptor that serves as a main doorway for the HIV virus into immune cells." It will be marketed as…
Douglas A. McIntyre Below are key short interest statistics for July. The figures are as of July 13 compared to June 15, 2007 Largest Short Positions Company …
(ABT) Abbott Labs $0.69 EPS vs $0.68 estimate; guidance looks soft.(ASD) American Standard $0.84 EPS net, but $1.05 before items; estimates were $1.08. Spin-off/sale remains on track. (BLK) Blackrock $1.80 EPS vs…
Not a good quarter for Pfizer (PFE). Second quarter revenue fell 6% to $11.1 billion. Net income was down 48% to $1.3 billion. The loss of U.S. exclusivity for Zoloft and Norvasc…
Douglas A. McIntyre MONDAYMattel (NYSE:MAT)Novellus (NASDAQ:NVLS)Philips Electronics (NYSE:PHG/ADR)W.W. Grainger (NYSE:GWW) TUESDAYJohnson & Johnson (NYSE:JNJ)Intel Corporation (NASDAQ: INTC)Merrill Lynch (NYSE:MER)Novartis (NYSE:NVS/ADR)Pharmaceutical Product Development (NASDAQ:PPDI)SLM Corp. (NYSE:SLR)State Street (NYSE:STT)Coca Cola (NYSE:KO)Wells fargo (NYSE:WFC)Yahoo! (NASDAQ:YHOO) WEDNESDAYAbbott Labs (NYSE:ABT)Altria…
As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a bit of a mixed bag. GlaxoSmithkline (GSK) saw the lagest increase, but…
Stock Tickers: AA, AIG, AXP, BA, C, CAT, DD, DIS, GE, GM, HD, HON, HPQ, IBK, JNJ, JPM, KO, MCD, MMM, MRK, MO, MRK, PFE, PG, T, UTX, VZ, WMT, XOM As…
According to Reuters, the IPO for Blackstone priced at the high end of its range, raising $4.13 billion. Reuters writes that GE (GE) and Pearson (PSO) have dropped their potential bid for…
The NYSE released short interest in stocks traded on the exchange. The figures are as of June 15 and are compared to the comparable numbers at of May 15. Largest Shares Short…
According to Reuters, Home Depot (HD) weighed a cut in its credit rating against its decision to buy-back $22.5 billion in shares. Reuters writes that Yahoo! (YHOO) acquired sports site Rivals.com. Reuters…
Coley Pharmaceuticals (COLY) is yet another small-cap biopharma one-trick pony that fell apart like a cheap clock. Pfizer (PFE) had been conducting trials of a lung cancer drug licensed from Coley, and…
Douglas A. McIntyre Shares of microcap biotech Coley Pharmaceutical Group (COLY-NASDAQ) saw shares get pounded late on Wednesday afternoon. Right before 2:00 PM EST, the company announced that its partner Pfizer (PFE-NYSE) had discontinued and…
Stock Tickers: MRK, PFE, JNJ, GSK, SGP, LLY, WYE, NVS, NVO On tonight’s MAD MONEY on CNBC, Jim Cramer said he keeps getting asked about Big Pharma drug stocks. He’d rather focus…
Stock Tickers: AAPL, GOOG, RIMM, BA, UTX, ATI, RTP, RIO, FLR, SGR, PEP, KO, BUD, CAG, HNZ, CPB, HRL, K, GIS, KFT, MCD, MRK, PFE, ALO, PYX, HME, WTR, SNH, SRZ, PG,…
This weekend we have the mother of all future cancer treatment conferences: ASCO, or The American Society of Clinical Oncology. Cancer stocks in the last few weeks have been seeing a muted…